Statistics for Beta-amyloid-directed multitarget compounds for the treatment of Alzheimer`s disease (USA, concesión n° 9,238,626)
Total visits
| views | |
|---|---|
| Beta-amyloid-directed multitarget compounds for the treatment of Alzheimer`s disease (USA, concesión n° 9,238,626) | 73 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
Top country views
| views | |
|---|---|
| United States | 52 |
| Chile | 8 |
| Sweden | 3 |
| Kenya | 2 |
| Mexico | 1 |
Top city views
| views | |
|---|---|
| Miami | 37 |
| Santiago | 7 |
| Alameda | 5 |
| Los Angeles | 3 |
| Stockholm | 2 |
| Campbell | 1 |
| Sacramento | 1 |
| Villa Alemana | 1 |
| Zapopan | 1 |
| Åkersberga | 1 |